Utah Medical Products (NASDAQ:UTMD) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why

Utah Medical Products, Inc. (NASDAQ:UTMD)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $58.29 and traded as low as $56.02. Utah Medical Products shares last traded at $56.75, with a volume of 14,856 shares traded.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Utah Medical Products in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Utah Medical Products presently has a consensus rating of “Sell”.

Utah Medical Products Trading Up 0.8%

The stock has a market cap of $181.60 million, a price-to-earnings ratio of 16.03 and a beta of 0.33. The firm has a fifty day simple moving average of $56.95 and a 200-day simple moving average of $58.29.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. The company had revenue of $9.81 million during the quarter. Utah Medical Products had a return on equity of 9.89% and a net margin of 30.08%.

Utah Medical Products Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 5th. Investors of record on Tuesday, December 16th will be paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.31. The ex-dividend date of this dividend is Tuesday, December 16th. Utah Medical Products’s payout ratio is presently 35.03%.

Institutional Trading of Utah Medical Products

A number of institutional investors have recently bought and sold shares of UTMD. First Horizon Advisors Inc. boosted its holdings in Utah Medical Products by 159.7% during the second quarter. First Horizon Advisors Inc. now owns 587 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 361 shares during the last quarter. Everett Harris & Co. CA grew its holdings in shares of Utah Medical Products by 2.1% in the 2nd quarter. Everett Harris & Co. CA now owns 17,478 shares of the medical instruments supplier’s stock valued at $995,000 after buying an additional 362 shares during the period. Comerica Bank increased its position in shares of Utah Medical Products by 435.6% in the 3rd quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 440 shares in the last quarter. CWM LLC raised its stake in Utah Medical Products by 60.4% during the 3rd quarter. CWM LLC now owns 1,330 shares of the medical instruments supplier’s stock worth $84,000 after buying an additional 501 shares during the period. Finally, BNP Paribas Financial Markets raised its stake in Utah Medical Products by 89.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 501 shares during the period. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).